VACCINE

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement

More in VACCINE

  • Oxford-AstraZeneca COVID vaccine faces legal challenge in UK: Report

    Among the claimants for damages is Indian-origin Anish Tailor, whose wife - 35-year-old Alpa Tailor - died in April 2021, just under a month after having the vaccine. An inquest in September 2021 is said to have determined she died from blood clots and bleeding on the brain caused by VITT.

    oxford astrazeneca covid vaccine faces legal challenge in uk report
  • Meningococcal vaccine market to see big changes with launch of Pfizer’s Penbraya: GlobalData

    Reportedly, the Centres for Disease Control and Prevention’s (CDC) Advisory Committee on Immunisation Practices (ACIP) has also recommended administering Penbraya when both meningococcal groups A, C, W and Y (MenACWY) and meningococcal group B (MenB) vaccines are indicated at the same visit for healthy patients ages 16 to 23 years and patients ages 10 years and older who have certain underlying health conditions.

    meningococcal vaccine market to see big changes with launch of pfizer s penbraya globaldata
  • UK regulator approves Pfizer's hair loss drug

    The drug, branded as Litfulo, has been approved by UK's Medicines and Healthcare products Regulatory Agency (MHRA) for people aged 12 years and older suffering from severe alopecia areata.

    uk regulator approves pfizer s hair loss drug
  • COVID-19 treatments to enter the market with a hefty price tag

    Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost for now. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week.

    covid 19 treatments to enter the market with a hefty price tag
  • India records 26 new COVID cases

    The country's COVID case tally is 4.50 crore (4,50,01,176). The number of people who have recuperated from the disease has increased to 4,44,67,626 and the national recovery rate stands at 98.81 per cent, according to the health ministry's website.

    india records 26 new covid cases
  • India records 24 new COVID cases

    The country's COVID case tally is 4.50 crore (4,50,01,150). The number of people who have recuperated from the disease has increased to 4,44,67,608 and the national recovery rate stands at 98.81 per cent, according to the health ministry's website.

    india records 24 new covid cases
  • Nigeria struggles to contain worst diphtheria outbreak

    Three nurses care for a 10-year-old girl at a clinic treating dozens of patients in Kano, northern Nigeria, amid the country's worst diphtheria outbreak which has killed hundreds of people since the start of the year. Nigeria is battling to contain the outbreak, which has killed around 800 people and infected 14,000.

    nigeria struggles to contain worst diphtheria outbreak
  • India records 12 new COVID cases

    The country's COVID case tally is 4.50 crore (4,50,01,052). The number of people who have recuperated from the disease has increased to 4,44,67,496 and the national recovery rate stands at 98.81 per cent, according to the health ministry's website.

    india records 12 new covid cases
Advertisement